PaperPanda Equity Terminal

NAMS logo NAMS — NEWAMSTERDAM PHARMA COMPANY

CUSIP: N62509109 · Held by 5 superinvestors · Combined value: $348,299,951

Latest News

Loading financials…

Quarterly Activity Chart Adds vs. Reduces by Quarter
Green bars = share additions · Red bars = share reductions
Superinvestor Holders
# Investor % of Portfolio Value ($) Shares Recent Activity Share Change
1 Andreas Halvorsen 0.4% $147,461,130 4,203,567 REDUCE -2,271,967
2 Stanley Druckenmiller 2.4% $107,701,000 3,070,146 ADD +1,146,446
3 Lee Ainslie 0.7% $66,449,448 1,894,226 ADD +389,479
4 Ken Griffin 0.0% $26,294,109 749,547 ADD +464,486
5 Polen Capital 0.0% $394,264 11,239 NEW BUY +11,239

Who Owns NAMS? Superinvestor Holdings

NEWAMSTERDAM PHARMA COMPANY is held by 5 tracked superinvestors, with a combined position value of $348 million . The largest positions are held by Andreas Halvorsen (0.4% of portfolio), Stanley Druckenmiller (2.4% of portfolio), Lee Ainslie (0.7% of portfolio).

In the most recent quarter, 4 superinvestors added or initiated positions while 1 reduced or exited.